Abstract
A novel lucigenin@PS-COOH nanoplatform is developed for cTnT detection, featuring exceptional stability and biocompatibility. This robust immunosensing system offers a high-performance pathway for the early diagnosis of cardiac events.
Funding Information
  • Science and Technology Commission of Shanghai Municipality (24DX1400200)
  • National Natural Science Foundation of China (22225805)
  • National Natural Science Foundation of China (22378122)

This publication has 43 references indexed in Scilit: